Comments

Sarepta Therapeutics Stock Guidance

SRPTNASDAQ
Logo brought to you by Benzinga Data
PerksBuyCompare Brokers
PerksBuyCompare Brokers
$60.44
-1.32-2.14%
At close: -
$60.76
0.320.53%
After Hours: 7:39 PM EDT
Q1 2025 Earnings in 10 days from now on Tue May 6th, after the market close
Sarepta Therapeutics (SRPT) ForecastNewsEarningsSarepta Therapeutics (SRPT) Options

Guidance

DividendsAnalyst RatingsInsider TradesGovernment TradesShort Interest

Sarepta Therapeutics Stock Guidance | NASDAQ:SRPT | Benzinga

Sarepta Therapeutics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.

Get Alert
08/02/2022SRPT
Sarepta Therapeutics
FY2022———$905.00M$920.00M$899.91MGet Alert
03/01/2022SRPT
Sarepta Therapeutics
FY2022———$880.00M—$908.46MGet Alert
01/10/2022SRPT
Sarepta Therapeutics
Q42021———$178.70M$178.70M$197.25MGet Alert

FAQ

Q

What is the most recent guidance for Sarepta Therapeutics (SRPT)?

A

There have been no specific sales or earnings guidance reported for Sarepta Therapeutics in recent months.

Browse guidance and forecast on all stocks.

People Also Watch

Connect With Us

instagramlinkedinyoutube

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell

© 2025 Benzinga | All Rights Reserved